Pharmaceutical Grade PVDC Sales

Pharmaceutical Grade PVDC Sales Market Outlook

The global Pharmaceutical Grade PVDC market is projected to reach a value of approximately USD 2.5 billion by 2035, growing at a Compound Annual Growth Rate (CAGR) of around 6.2% during the forecast period of 2025 to 2035. This growth is primarily driven by the increasing demand for high-quality packaging materials in the pharmaceutical sector, bolstered by the need for enhanced barrier properties and product protection. Moreover, the rising prevalence of chronic diseases and an expanding range of pharmaceutical products, including biologics and personalized medicine, are further propelling the market. The growing focus on sustainability and the development of eco-friendly packaging solutions also contribute significantly to the market expansion. As the pharmaceutical industry continues to innovate and evolve, the demand for reliable and efficient packaging materials such as PVDC is expected to witness substantial growth, positioning the market for a promising future.

Growth Factor of the Market

One of the primary growth factors influencing the Pharmaceutical Grade PVDC market is the increasing emphasis on product safety and efficacy in pharmaceuticals. As pharmaceutical companies face stringent regulations and quality standards set by authorities like the FDA and EMA, the need for superior barrier materials becomes crucial. PVDC offers excellent moisture, oxygen, and light barrier properties, making it an ideal choice for preserving the integrity of sensitive medications. Furthermore, the rapid advancements in the pharmaceutical sector, including the development of advanced drug delivery systems and biologics, create a substantial demand for innovative packaging solutions. The trend towards personalized medicine is also driving the need for customized packaging, which PVDC can effectively provide. Additionally, the growing global population and the subsequent rise in healthcare spending are fostering an environment conducive to market growth. Increased investments in research and development by pharmaceutical companies to introduce new products and improve existing ones are also pivotal in driving demand for PVDC packaging solutions.

Key Highlights of the Market

• The market is expected to achieve a CAGR of 6.2% from 2025 to 2035.
• North America and Europe are the leading regions in terms of market share, driven by high pharmaceutical production rates.
• The demand for PVDC-coated films and capsules is significantly rising due to their enhanced barrier properties.
• There is an increased focus on sustainable practices, leading to innovations in eco-friendly PVDC packaging solutions.
• Expanding online distribution channels are anticipated to boost market accessibility and reach.

By Product Type

Pellets:

Pellets are a crucial product type in the Pharmaceutical Grade PVDC market, primarily utilized in the production of various pharmaceutical formulations. These pellets are characterized by their uniform size and shape, facilitating accurate dosing and consistency in medication. The increasing adoption of pellet technology in drug formulation is driven by its advantages, such as enhanced bioavailability and controlled release properties. Additionally, the demand for pellets is expected to rise as pharmaceutical companies focus on developing advanced drug delivery systems, which require high-quality excipients like PVDC pellets. Furthermore, the versatility of pellets in formulating different dosage forms such as tablets and capsules adds to their attractiveness in the market.

Coated Films:

Coated films represent another significant segment within the Pharmaceutical Grade PVDC market, known for their excellent barrier properties that protect pharmaceutical products from moisture, oxygen, and light. These films are widely used in various applications, including blister packaging, which is a preferred choice for unit dose packaging in the pharmaceutical industry. The growing trend towards innovative packaging solutions that enhance product shelf life and maintain drug stability is driving the demand for PVDC-coated films. As more pharmaceutical companies seek to improve their packaging designs for market competitiveness, the coated films segment is expected to witness substantial growth in the coming years.

Coated Blisters:

Coated blisters are a specialized form of PVDC packaging widely used for containing solid dosage forms such as tablets and capsules. The need for coated blisters is increasing due to their ability to provide superior protection against environmental factors that could affect drug efficacy. The application of PVDC coatings enhances the barrier properties of blister packs, making them suitable for sensitive medications that require a controlled atmosphere. Moreover, the trend of unit-dose packaging in the pharmaceutical industry is further fueling the growth of this segment. As the pharmaceutical sector continues to prioritize patient safety and medication adherence, the demand for coated blisters is anticipated to rise significantly.

Coated Capsules:

Coated capsules are gaining traction within the Pharmaceutical Grade PVDC market due to their advantages in drug formulation and delivery. The use of PVDC to coat capsules enhances their mechanical strength and improves their barrier capabilities, protecting the active ingredients from degradation caused by moisture and oxygen. This is particularly important for sensitive compounds that have low stability. Moreover, the convenience of capsules as a dosage form, coupled with the growing consumer preference for non-tablet forms of medication, is driving the demand for coated capsules. With the continuous innovation in capsule technology, the market for PVDC-coated capsules showcases promising growth potential.

Coated Granules:

Coated granules are another critical product type in the Pharmaceutical Grade PVDC market, offering unique benefits in drug formulation. These granules are often used in direct compression processes and are favored for their uniformity in dosing and ease of handling. The application of PVDC coatings enhances the flow properties of granules, making them ideal for manufacturing tablets with consistent quality and performance. As the pharmaceutical industry increasingly adopts granulation techniques for new drug formulations, the demand for PVDC-coated granules is expected to rise significantly. This segment holds strong growth potential, particularly in the context of new product development and formulation innovations.

By Application

Tablets:

Tablets are one of the primary applications for Pharmaceutical Grade PVDC, leveraging its exceptional barrier properties to ensure the stability and efficacy of pharmaceutical products. PVDC coatings play a pivotal role in protecting active ingredients from moisture, oxygen, and light—factors that can compromise drug quality. The demand for tablets is steadily increasing due to their widespread acceptance and convenience among consumers. Additionally, the rising prevalence of chronic diseases, leading to increased medication adherence requirements, is positively influencing the tablet segment. As manufacturers seek to enhance tablet formulations, the utilization of PVDC as a coating agent is expected to grow significantly.

Capsules:

Capsules serve as a major application area for Pharmaceutical Grade PVDC, particularly in the context of oral dosage forms. The benefits of PVDC coatings contribute to the stability and shelf life of capsules, which are often preferred by patients for their ease of swallowing. The growing demand for customized and targeted drug delivery solutions is also driving the use of capsules in pharmaceutical formulations. As the industry continues to innovate with capsule technologies, including extended-release and enteric-coated options, the incorporation of PVDC in these products is likely to see substantial growth, supported by consumer preferences for effective and palatable forms of medication.

Powders:

Powders represent another significant application within the Pharmaceutical Grade PVDC market, primarily utilized in the formulation of various medications. PVDC coatings enhance the stability and flow of powders, facilitating their effective use in solid dosage forms. The increasing demand for powder formulations in the pharmaceutical industry is driven by the growing incidence of respiratory diseases, leading to a rise in inhalation powder products. Furthermore, the trend toward developing new formulations to improve bioavailability and pharmacokinetics is pushing manufacturers to explore PVDC as a viable option for powder coatings, highlighting the segment's growth potential in the evolving pharmaceutical landscape.

Pellets:

The application of pellets in the Pharmaceutical Grade PVDC market is closely linked to their use in advanced drug delivery systems. As pharmaceutical companies focus on developing controlled-release formulations, the demand for PVDC-coated pellets is on the rise. These pellets offer a versatile approach to delivering active ingredients while ensuring stability and protecting them from environmental factors. The growth in personalized medicine and the increasing adoption of pellet technology in various therapeutic areas are further driving the demand in this segment. As more innovative formulations emerge, the application of PVDC in pellets is poised for significant growth.

Liquids:

Liquids are a growing application area for Pharmaceutical Grade PVDC, particularly in the context of suspensions and emulsions. PVDC coatings enhance the stability of liquid formulations by providing a protective barrier against degradation and contamination. The increasing demand for liquid medications, especially among pediatric and geriatric populations, is propelling the growth of this segment. Additionally, the rise in biopharmaceuticals and biologics, which often require liquid formulations, further boosts the need for effective packaging solutions. As the liquid pharmaceutical market expands, the role of PVDC in ensuring the safety and efficacy of these products will become increasingly significant.

By Distribution Channel

Online Stores:

Online stores have emerged as a prominent distribution channel in the Pharmaceutical Grade PVDC market, driven by the growing trend of e-commerce and changing consumer preferences. This channel offers convenience and accessibility for customers seeking pharmaceutical products, allowing them to compare prices and make informed purchasing decisions. The rise of online pharmacies has been accelerated by the COVID-19 pandemic, leading to increased sales of pharmaceutical products through digital platforms. As more consumers embrace online shopping for health-related products, the demand for PVDC packaging solutions in this channel is expected to grow significantly, reflecting the evolving landscape of pharmaceutical distribution.

Drug Stores:

Drug stores continue to be a critical distribution channel for Pharmaceutical Grade PVDC, serving as a primary point of access for consumers seeking medications and health products. The presence of licensed pharmacists in drug stores adds an element of trust, which is essential for consumers when purchasing pharmaceutical products. The consistent demand for PVDC packaging in drug stores is influenced by the wide variety of medications available, including prescription and over-the-counter drugs. As the pharmaceutical sector continues to expand, drug stores are expected to maintain their relevance, ensuring a steady demand for reliable PVDC packaging solutions.

Retail Pharmacies:

Retail pharmacies play an essential role in the distribution of Pharmaceutical Grade PVDC, catering to local communities and providing a convenient option for obtaining medications. The competitive nature of the retail pharmacy market drives them to seek high-quality packaging solutions that enhance product safety and shelf life. The growing trend of health consciousness among consumers is leading to increased foot traffic in retail pharmacies, which positively impacts the demand for PVDC packaging. As pharmacies adopt new strategies to improve customer experience and diversify their product offerings, the need for effective packaging solutions like PVDC is expected to rise.

Hospital Pharmacies:

Hospital pharmacies are integral distribution channels for Pharmaceutical Grade PVDC, particularly in supplying medications for inpatient and outpatient care. These pharmacies focus on providing high-quality, safe, and effective medications for patients, making reliable packaging essential. The demand for PVDC in hospital pharmacies is influenced by the growing need for stability and protection of injectable and infusible medications. Additionally, the increasing patient turnover in hospitals contributes to the rising demand for pharmaceutical products that require advanced packaging solutions. As hospitals continue to prioritize patient safety and medication management, the role of PVDC in hospital pharmacies will remain critical.

Direct Sales:

Direct sales as a distribution channel for Pharmaceutical Grade PVDC involve manufacturers selling their products directly to healthcare providers, ensuring a streamlined supply chain. This approach allows for better control over product quality and customer relationships, fostering trust between manufacturers and end-users. The direct sales channel is particularly relevant in the pharmaceutical industry, where specialized products require tailored support and education. As companies aim to establish closer connections with healthcare professionals and institutions, the demand for PVDC in direct sales is expected to grow, reflecting the importance of building strong partnerships in the pharmaceutical landscape.

By Ingredient Type

PVDC Resins:

PVDC resins are a core ingredient type in the Pharmaceutical Grade PVDC market, known for their exceptional barrier properties and chemical resistance. These resins are primarily used in the production of films and coatings for pharmaceutical packaging. The increasing demand for high-performance packaging materials in the pharmaceutical industry is driving the growth of PVDC resins. The versatility of PVDC allows for its application across various dosage forms, including tablets, capsules, and liquids, ensuring product stability and efficacy. As manufacturers continue to innovate and develop new formulations, the demand for PVDC resins is anticipated to rise significantly.

PVDC Coatings:

PVDC coatings play a vital role in the Pharmaceutical Grade PVDC market, providing advanced barrier protection and enhancing the performance of pharmaceutical products. The application of PVDC coatings ensures that active ingredients are shielded from moisture, oxygen, and light, which can degrade their efficacy. The growing focus on sustainability and eco-friendly practices in the pharmaceutical industry is also influencing the use of PVDC coatings, as they offer recyclable options for packaging materials. As pharmaceutical companies increasingly prioritize product quality and safety, the demand for PVDC coatings is expected to experience significant growth, reinforcing their importance in the market.

By Region

The North American region dominates the Pharmaceutical Grade PVDC market, accounting for approximately 40% of the total market share in 2025. The presence of a robust pharmaceutical industry, coupled with stringent regulatory requirements, drives the demand for high-quality PVDC packaging solutions. Additionally, the increasing prevalence of chronic diseases and the need for innovative drug delivery systems contribute to the region's growth. The market in North America is projected to achieve a CAGR of 6.5% from 2025 to 2035, reflecting the ongoing advancements in pharmaceutical formulations and packaging technologies.

In Europe, the Pharmaceutical Grade PVDC market is experiencing significant growth, fueled by the increasing focus on research and development in the pharmaceutical sector. The region is home to several leading pharmaceutical companies that prioritize the adoption of advanced packaging solutions to comply with strict regulatory standards. The market in Europe is anticipated to account for approximately 30% of the global market share by 2035. The rising demand for personalized medicine and biologics is further bolstering the need for PVDC packaging, as manufacturers seek to enhance product stability and patient safety. The Asia Pacific region is also witnessing a surge in demand, driven by rapid industrialization and increasing healthcare expenditures, contributing to the overall growth of the market.

Opportunities

The Pharmaceutical Grade PVDC market presents numerous opportunities for growth, particularly as the pharmaceutical industry continues to innovate and expand. One significant opportunity lies in the development of eco-friendly PVDC packaging solutions that align with the growing emphasis on sustainability. With increasing consumer preference for environmentally conscious products, manufacturers have the chance to invest in research and development to create biodegradable or recyclable PVDC materials. This shift not only meets regulatory and consumer demands but also positions companies favorably in a competitive market. Furthermore, partnerships and collaborations between packaging manufacturers and pharmaceutical companies can lead to the development of customized solutions that enhance product safety and efficacy, creating a win-win scenario for both parties involved.

Additionally, the increasing focus on emerging markets presents a wealth of opportunities for the Pharmaceutical Grade PVDC market. As countries in Asia Pacific, Latin America, and Africa experience rapid growth in their pharmaceutical sectors, the demand for reliable and effective packaging solutions is set to rise. Companies that establish a strong presence in these regions can benefit from the expanding healthcare infrastructure and increasing healthcare spending. Moreover, the growing prevalence of chronic diseases in these regions necessitates the need for advanced packaging materials that ensure product stability and safety. By tapping into these emerging markets and catering to their specific needs, businesses can unlock significant revenue streams and contribute to the overall growth of the Pharmaceutical Grade PVDC market.

Threats

Despite the promising growth prospects of the Pharmaceutical Grade PVDC market, several threats could hinder its progress. One of the primary threats is the increasing competition from alternative packaging materials that offer similar barrier properties and functionality. For instance, advancements in sustainable packaging options such as biodegradable plastics and aluminum foil could pose a challenge to PVDC's market share. As companies strive for cost-effectiveness and sustainability, there is a risk that PVDC may be overlooked in favor of these alternatives. Additionally, fluctuations in raw material prices for producing PVDC can impact profitability and lead to supply chain disruptions, affecting manufacturers' ability to meet market demands.

Another significant threat facing the Pharmaceutical Grade PVDC market is the evolving regulatory landscape. As governments and regulatory bodies introduce new standards and guidelines for pharmaceutical packaging, manufacturers must continuously adapt to comply with these changes. Non-compliance may result in product recalls, legal penalties, and reputational damage, which can adversely affect market players. Furthermore, the ongoing global challenges posed by events such as the COVID-19 pandemic have highlighted vulnerabilities in supply chains, leading to potential disruptions in the availability of pharmaceutical products and their packaging materials. As companies navigate this complex landscape, they must remain agile and proactive to mitigate risks and ensure continued growth.

Competitor Outlook

• Westlake Chemical Corporation
• Solvay S.A.
• PolyOne Corporation
• DuPont de Nemours, Inc.
• BASF SE
• Evonik Industries AG
• 3M Company
• Christie Digital Systems USA, Inc.
• H.B. Fuller Company
• Clariant AG
• Ferro Corporation
• SABIC
• Shin-Etsu Chemical Co., Ltd.
• Alpek S.A.B. de C.V.
• Celanese Corporation
• Rohm and Haas Company

The competitive landscape of the Pharmaceutical Grade PVDC market is characterized by a diverse range of players, including multinational corporations and specialized packaging manufacturers. These companies are heavily invested in research and development to innovate and enhance their product offerings. The competition is primarily driven by the need for improved packaging solutions that ensure product safety, stability, and regulatory compliance. Additionally, players are focusing on strategic collaborations, mergers, and acquisitions to expand their market presence and leverage synergies in technology and resources. The market is witnessing a trend towards sustainability, with companies exploring eco-friendly alternatives and practices to meet consumer expectations and regulatory demands.

Among the leading companies in the Pharmaceutical Grade PVDC market, Westlake Chemical Corporation stands out for its extensive portfolio of polymer products and innovative packaging solutions. The company is committed to providing high-quality materials that meet the stringent requirements of the pharmaceutical industry. Solvay S.A. is another key player known for its advanced PVDC technology and focus on sustainable practices. The company invests significantly in research to develop new formulations that enhance product performance and environmental compatibility. Similarly, DuPont de Nemours, Inc. is recognized for its expertise in barrier materials and continually seeks to innovate its product lines to address the evolving needs of the pharmaceutical sector.

BASF SE is also a major competitor in the Pharmaceutical Grade PVDC market, leveraging its vast experience in chemical manufacturing and commitment to research and development. The company's focus on creating sustainable packaging solutions aligns with market trends and consumer preferences, positioning it as a key player in the industry. Additionally, Evonik Industries AG is known for its comprehensive range of PVDC materials, emphasizing advanced barrier technologies. The company actively collaborates with pharmaceutical manufacturers to develop tailored solutions that enhance product delivery and stability. As the market continues to develop, these major companies and others will play a pivotal role in shaping the future of the Pharmaceutical Grade PVDC industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 SABIC
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 BASF SE
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 3M Company
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Clariant AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Solvay S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Ferro Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 H.B. Fuller Company
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 PolyOne Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Alpek S.A.B. de C.V.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Celanese Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Evonik Industries AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Rohm and Haas Company
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 DuPont de Nemours, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Shin-Etsu Chemical Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Westlake Chemical Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis
  • 5.16 Christie Digital Systems USA, Inc.
    • 5.16.1 Business Overview
    • 5.16.2 Products & Services
    • 5.16.3 Financials
    • 5.16.4 Recent Developments
    • 5.16.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Pharmaceutical Grade PVDC Sales Market, By Application
    • 6.1.1 Tablets
    • 6.1.2 Capsules
    • 6.1.3 Powders
    • 6.1.4 Pellets
    • 6.1.5 Liquids
  • 6.2 Pharmaceutical Grade PVDC Sales Market, By Product Type
    • 6.2.1 Pellets
    • 6.2.2 Coated Films
    • 6.2.3 Coated Blisters
    • 6.2.4 Coated Capsules
    • 6.2.5 Coated Granules
  • 6.3 Pharmaceutical Grade PVDC Sales Market, By Distribution Channel
    • 6.3.1 Online Stores
    • 6.3.2 Drug Stores
    • 6.3.3 Retail Pharmacies
    • 6.3.4 Hospital Pharmacies
    • 6.3.5 Direct Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Pharmaceutical Grade PVDC Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Pharmaceutical Grade PVDC Sales market is categorized based on

By Product Type

• Pellets
• Coated Films
• Coated Blisters
• Coated Capsules
• Coated Granules

By Application

• Tablets
• Capsules
• Powders
• Pellets
• Liquids

By Distribution Channel

• Online Stores
• Drug Stores
• Retail Pharmacies
• Hospital Pharmacies
• Direct Sales

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Westlake Chemical Corporation
• Solvay S.A.
• PolyOne Corporation
• DuPont de Nemours, Inc.
• BASF SE
• Evonik Industries AG
• 3M Company
• Christie Digital Systems USA, Inc.
• H.B. Fuller Company
• Clariant AG
• Ferro Corporation
• SABIC
• Shin-Etsu Chemical Co., Ltd.
• Alpek S.A.B. de C.V.
• Celanese Corporation
• Rohm and Haas Company